FDA Adverse Event Injury Summary report: N

VISCOAT OPHTHALMIC VISCOSURGICAL DEVICE

MDR report key: 15806002 · Received November 16, 2022

Report

Report Number
3002037047-2022-00071
Event Type
Injury
Date Received
November 16, 2022
Date of Event
November 1, 2022
Report Date
February 17, 2023
Manufacturer
ALCON - COUVREUR N.V./ALCON - BELGIUM
Product Code
LZP
PMA / PMN Number
P840064
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
GM
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

INVESTIGATION INCLUDING ROOT CAUSE ANALYSIS IS IN PROGRESS. A SUPPLEMENTAL MDR WILL BE FILED AS NECESSARY IN ACCORDANCE WITH 21 CFR 803.56 WHEN ADDITIONAL REPORTABLE INFORMATION BECOMES AVAILABLE. LITERATURE ARTICLE: OLIVER SCHWENN, H. BURKHARD DICK, FRANK KRUMMENAUER, STEFAN CHRISTMANN, ANNETTE VOGEL, NORBERT PFEIFFER " HEALON5 VERSUS VISCOAT DURING CATARACT SURGERY: INTRAOCULAR PRESSURE, LASER FLARE AND CORNEAL CHANGES " (GRAEFE¿S ARCH CLIN EXP OPHTHALMOL 2000 861-867). THE MANUFACTURER INTERNAL REFERENCE NUMBER IS: (B)(4).

Additional Manufacturer Narrative · 0

NO LOT CODE OR SAMPLE PROVIDED AS THIS COMPLAINT IS RELATED TO A LITERATURE ARTICLE. NO FURTHER EVALUATION OR ROOT CAUSE ANALYSIS CAN BE CONDUCTED AT THIS TIME. NO ROOT CAUSE COULD BE DETERMINED AS NO SAMPLE OR LOT CODE WAS PROVIDED FOR ANALYSIS. NO ACTION IS WARRANTED. THE MANUFACTURER INTERNAL REFERENCE NUMBER IS: (B)(4).

Description of Event or Problem · 0

A STUDY REPORTED THAT AN OPHTHALMIC VISCO SURGICAL DEVICE WAS USED IN A PROCEDURE AND TWO PATIENTS EXPERIENCED INCREASED INTRA OCULAR PRESSURE (IOP) AND PROVIDED WITH CARBONIC ANHYDRASE INHIBITORS. NO FURTHER INFORMATION EXPECTED DUE TO THE UNLIKELIHOOD OF OBTAINING THE INFORMATION.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
356766 VISCOAT OPHTHALMIC VISCOSURGICAL DEVICE AID, SURGICAL, VISCOELASTIC LZP ALCON - COUVREUR N.V./ALCON - BELGIUM NA ASKU

Patients

Seq Age Sex Outcome Treatment
1 Unknown Other| R ACETAZOLAMIDE